In the face of rising product safety concerns, the stakes are higher than ever for companies to ensure they have the most effective procedures in place to manage potential recalls and curb their liability and damage exposure, product liability lawyers say.
A federal appeals court has upheld two lower court decisions that found Argentinean plaintiffs’ product liability actions filed in the United States against Bayer Corp. and Bridgestone/Firestone North American Tire LLC and others were brought in the wrong forum and should proceed in Argentina.
The Supreme Court of Arkansas has overturned two provisions of state tort law, finding that one limiting the liability of nonparties and another dictating what medical expenses can be presented at trial are unconstitutional.
A biocide in furniture and shoes that causes severe allergic reactions in some has been banned from the European Union, after an emergency decision by the European Commission.
At a hearing Friday in the Zyprexa multidistrict litigation, counsel for a class of third-party payors urged the court to divulge the names of physicians who may have overprescribed the drug at the behest of Eli Lilly & Co. representatives, while the pharmaceutical company argued the identities were immaterial to the case.
A federal judge has dismissed a suit by a putative class of patients and their insurer Zurich Insurance Co. alleging that biotechnology company InterMune Inc. fraudulently promoted its drug Actimmune as a valid remedy for a lung disease it is not approved to treat.
More than a year after initiating a safety review, the U.S. Food and Drug Administration has ordered its strictest safety warning to be attached to Allergan Inc.'s Botox and other similar products amid fears that the potentially deadly toxins could spread beyond the point of injection.
A Roche Holding AG subsidiary has recalled insulin pumps after discovering that some of the pumps’ “up” and “down” buttons did not work properly.
Agents from the U.S. Environmental Protection Agency looking for evidence of environmental crimes executed federal search warrants on Wednesday at government offices in the Village of Crestwood, Ill.
The U.S. Environmental Protection Agency's managers and its scientists had deep, potentially dangerous disagreements over the cleanup in asbestos-contaminated Libby, Mont., according to an internal memo released by the agency.
Health food and supplement maker Nature & Health Co. has issued a recall of male enhancement product Libimax following the U.S. Food and Drug Administration's discovery that the product contains tadalafil, an active ingredient used in erectile dysfunction drugs, without agency approval or a label listing the ingredient.
A federal appellate court has sent two cases, one against Apotex Inc. and GlaxoSmithKline PLC and the other against Pfizer Inc., back to the lower courts for reconsideration in light of the U.S. Supreme Court's blockbuster preemption decision in Wyeth v. Levine.
A bill introduced in the U.S. House of Representatives by Rep. Bart Stupak, D-Mich., would empower border agents to prohibit the import of substandard drywall, a product that has vexed homeowners and sparked dozens of lawsuits.
The judge in a criminal case alleging W.R. Grace & Co. and its executives hid asbestos dangers has upbraided the prosecution for spotty compliance with disclosure rules and incompetence, though he stopped short of dismissing the indictment because of prosecutorial misconduct.
The U.S. Consumer Product Safety Commission has unveiled new guidelines for testing the amount of lead in paint and other surface coatings.
A Michigan health commissioner and workers' compensation provider have filed suit against Merck & Co., claiming that the pharmaceutical giant owes them damages connected to their unknowingly continuing to prescribe the now-yanked painkiller Vioxx, which has been found to double the risk of strokes and heart attacks.
A bill proposed by Sens. Chuck Grassley, R-Iowa, and Edward Kennedy, D-Mass., would boost the U.S. Food and Drug Administration's authority to hold accountable foreign medical device and drug manufacturers, putting pressure on smaller U.S. companies that rely on imports to ensure those producers meet U.S. safety codes.
A Philadelphia appeals court has overturned a $5 million verdict awarded to the parents of an infant who died after taking too much of McNeil PPC Inc.’s Infants' Tylenol formulation.
Bankrupt mining firm Asarco LLC has filed the disclosure statement for its fourth amended plan of reorganization, which incorporates a judge's approval of a $1.7 billion sale of its operating assets to India-based copper producer Sterlite Industries Ltd.
A 38-state coalition has launched an investigation into Bristol-Myers Squibb Co. for alleged violations of state consumer protection laws in its marketing of anti-psychotic Abilify.